Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice

Human Gene Therapy

Volumn 19, Issue 11, 2008, Pages 1317-1323

  Tittiger, Mindy ^a   Ma, Xiucui ^a   Xu, Lingfei ^a   Ponder, Katherine P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; GAMMARETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSDUCTION; HEMATOPOIETIC SYSTEM TUMOR; LIVER ADENOMA; LIVER CELL; LONG TERMINAL REPEAT; MOUSE; MUCOPOLYSACCHARIDOSIS; NEWBORN; NONHUMAN; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; RISK ASSESSMENT; SURVIVAL RATE;

ADENOMA; ANIMALS; ANIMALS, NEWBORN; CARCINOMA, HEPATOCELLULAR; DOGS; GAMMARETROVIRUS; GENETIC VECTORS; GLUCURONIDASE; HEMATOLOGIC NEOPLASMS; INCIDENCE; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SURVIVAL RATE; TRANSDUCTION, GENETIC;

MUS;

EID: 57049186467     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.070     Document Type: Article

References (47)

1. Aiuti, A., Cassani, B., Andolfi, G., Mirolo, M., Biasco, L., Recchia, A., Urbinati, F., Valacca, C., Scaramuzza, S., Aker, M., Slavin, S., Cazzola, M., Sartori, D., Ambrosi, A., Di Serio, C., Roncarolo, M.G., Mavilio, F., and Bordignon, C. (2007). Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J. Clin. Invest. 117, 2233-2240.
2. Baum, C. (2007a). What are the consequences of the fourth case? Mol. Ther. 15, 1401-1402.
3. Baum, C. (2007b). Insertional mutagenesis in gene therapy and stem cell biology. Curr. Opin. Hematol. 14, 337-342.
4. Beard, B.C., Dickerson, D., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D.G., Jacobs, M.A., Kaul, R., Kiem, H.P., and Trobridge, G.D. (2007a). Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol. Ther. 15, 1356-1365.
5. Beard, B.C., Keyser, K.A., Trobridge, G.D., Peterson, L.J., Miller, D.G., Jacobs, M., Kaul, R., and Kiem, H.P. (2007b). Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum. Gene Ther. 18, 423-434.
6. Boelens, J.J., Wynn, R.F., O'Meara, A., Veys, P., Bertrand, Y., Souillet, G., Wraith, J.E., Fischer, A., Cavazzana-Calvo, M., Sykora, K.W., Sedlacek, P., Rovelli, A., Uiterwaal, C.S., and Wulffraat, N. (2007). Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: A risk factor analysis for graft failure. Bone Marrow Transplant. 40, 225-233.
7. Bushman, F.D. (2007). Retroviral integration and human gene therapy. J. Clin. Invest. 117, 2083-2086.
8. Calmels, B., Ferguson, C., Laukkanen, M.O., Adler, R., Faulhaber, M., Kim, H.J., Sellers, S., Hematti, P., Schmidt, M., von Kalle, C., Akagi, K., Donahue, R.E., and Dunbar, C.E. (2005). Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 106, 2530-2533.
9. Cole, A. (2008). Child in gene therapy programme develops leukaemia. BMJ 336, 13.
10. Deichmann, A., Hacein-Bey-Abina, S., Schmidt, M., Garrigue, A., Brugman, M.H., Hu, J., Glimm, H., Gyapay, G., Prum, B., Fraser, C.C., Fischer, N., Schwarzwaelder, K., Siegler, M.L., de Ridder, D., Pike-Overzet, K., Howe, S.J., Thrasher, A.J., Wagemaker, G., Abel, U., Staal, F.J., Delabesse, E., Villeval, J.L., Aronow, B., Hue, C., Prinz, C., Wissler, M., Klanke, C., Weissenbach, J., Alexander, I., Fischer, A., von Kalle, C., and Cavazzana-Calvo, M. (2007). Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J. Clin. Invest. 117, 2225-2232.
11. Di Domenico, C., Di Napoli, D., Gonzalez, Y., Reyero, E., Lombardo, A., Naldini, L., and Di Natale, P. (2006). Limited transgene immune response and long-term expression of human α-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy. Hum. Gene Ther. 17, 1112-1121.
12. Du, Y., Jenkins, N.A., and Copeland, N.G. (2005). Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106, 3932-3939.
13. Ferry, C., Gemayel, G., Rocha, V., Labopin, M., Esperou, H., Robin, M., de Latour, R.P., Ribaud, P., Devergie, A., Leblanc, T., Gluckman, E., Baruchel, A., and Socié, G. (2007). Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant. 40, 219-224.
14. Frith, C.H., Ward, J.M., and Chandra, M. (1993). The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol. Pathol. 21, 206-218.
15. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., and Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
16. Kobayashi, H., Carbonaro, D., Pepper, K., Petersen, D., Ge, S., Jackson, H., Shimada, H., Moats, R., and Kohn, D.B. (2005). Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol. Ther. 11, 776-789.
17. Liu, Y., Xu, L., Hennig, A.K., Kovacs, A., Fu, A., Chung, S., Lee, D., Wang, B., Herati, R.S., Mosinger Ogilvie, J., Cai, S.R., and Parker Ponder, K. (2005). Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Mol. Ther. 11, 35-47.
18. Métais, J.Y., and Dunbar, C.E. (2008). The MDS1-EVI1 gene complex as a retrovirus integration site: Impact on behavior of hematopoietic cells and implications for gene therapy. Mol. Ther. 16, 439-449.
19. Miller, D.G., Adam, M.A., and Miller, A.D. (1990). Gene transfer by retroviral vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
20. Modlich, U., Bohne, J., Schmidt, M., von Kalle, C., Knoss, S., Schambach, A., and Baum, C. (2006). Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 108, 2545-2553.
21. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi Sergi, L., Benedicenti, F., Ambrosi, A., Di Serio, C., Doglioni, C., von Kalle, C., and Naldini, L. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24, 687-696.
22. Naldini, L., Blomer, U., Galley, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
23. Nienhuis, A.W., Dunbar, C.E., and Sorrentino, B.P. (2006). Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 13, 1031-1049.
24. Ott, D.E., Keller, J., Sill, K., and Rein, A. (1992). Phenotypes of murine leukemia virus-induced tumors: Influence of 3′ viral coding sequences. J. Virol. 66, 6107-6116.
25. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N.A., Copeland, N.G., Luthi, U., Hassan, M., Thrasher, A.J., Hoelzer, D., von Kalle, C., Seger, R., and Grez, M. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
26. Ponder, K.P. (1996). Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies. FASEB J. 10, 673-682.
27. Ponder, K.P. (2006). Gene therapy for hemophilia. Curr. Opin. Hematol. 13, 301-307.
28. Ponder, K.P., and Haskins, M.E. (2007). Gene therapy for mucopolysaccharidosis. Expert Opin. Biol. Ther. 7, 1333-1345.
29. Ponder, K.P., Melniczek, J.R., Xu, L., Weil, M.A., O'Malley, T.M., O'Donnell, P.A., Knox, V.W., Aguirre, G.D., Mazrier, H., Ellinwood, N.M., Sleeper, M., Maguire, A.M., Volk, S.W., Mango, R.L., Zweigle, J., Wolfe, J.H., and Haskins, M.E. (2002). Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc. Natl. Acad. Sci. U.S.A. 99, 13102-13107.
30. Sands, M.S., and Davidson, B.L. (2006). Gene therapy for lysosomal storage diseases. Mol. Ther. 13, 839-849.
31. Schambach, A., Mueller, D., Galla, M., Verstegen, M.M., Wagemaker, G., Loew, R., Baum, C., and Bohne, J. (2006). Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther. 13, 1524-1533.
32. Schwarzwaelder, K., Howe, S.J., Schmidt, M., Brugman, M.H., Deichmann, A., Glimm, H., Schmidt, S., Prinz, C., Wissler, M., King, D.J., Zhang, F., Parsley, K.L., Gilmour, K.C., Sinclair, J., Bayford, J., Peraj, R., Pike-Overzet, K., Staal, F.J., de Ridder, D., Kinnon, C., Abel, U., Wagemaker, G., Gaspar, H.B., Thrasher, A.J., and von Kalle, C. (2007). Gammaretrovirus- mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J. Clin. Invest. 117, 2241-2249.
33. Seggewiss, R., Pittaluga, S., Adler, R.L., Guenaga, F.J., Ferguson, C., Pilz, I.H., Ryu, B., Sorrentino, B.P., Young, W.S. 3rd, Donahue, R.E., von Kalle, C., Nienhuis, A.W., and Dunbar, C.E. (2006). Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque. Blood 107, 3865-3867.
34. Themis, M., Waddington, S.N., Schmidt, M., von Kalle, C., Wang, Y., Al-Allaf, F., Gregory, L.G., Nivsarkar, M., Themis, M., Holder, M.V., Buckley, S.M., Dighe, N., Ruthe, A.T., Mistry, A., Bigger, B., Rahim, A., Nguyen, T.H., Trono, D., Thrasher, A.J., Coutelle, C. (2005). Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol. Ther. 12, 763-771.
35. Thrasher, A.J., Gaspar, H.B., Baum, C., Modlich, U., Schambach, A., Candotti, F., Otsu, M., Sorrentino, B., Scobie, L., Cameron, E., Blyth, K., Neil, J., Abina, S.H., Cavazzana-Calvo, M., and Fischer, A. (2006). Gene therapy: X-SCID transgene leukaemogenicity. Nature 443, E5-E6.
36. Traas, A.M., Wang, P., Ma, X., Tittiger, M., Schaller, L., O'Donnell, P., Sleeper, M.M., Vite, C., Herati, R., Aguirre, G.D., Haskins, M., and Ponder, K.P. (2007). Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy. Mol. Ther. 15, 1423-1431.
37. Vanin, E.F., Kaloss, M., Broscius, C., and Nienhuis, A.W. (1994). Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68, 4241-4250.
38. Vogelstein, B., and Kinzler, K.W. (1993). The multistep nature of cancer. Trends Genet. 9, 138-141.
39. Volk, M.J., Pugh, T.D., Kim, M., Frith, C.H., Daynes, R.A., Ershler, W.B., and Weindruch, R. (1994). Dietary restriction from middle age attenuates age-associated lymphoma development and interleukin 6 dysregulation in C57BL/6 mice. Cancer Res. 54, 3054-3061.
40. Wang, B., O'Malley, T.M., Xu, L., Vite, C., Wang, P., O'Donnell, P.A., Ellinwood, N.M., Haskins, M.E., and Ponder, K.P. (2006). Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs. Mol. Genet. Metab. 87, 8-21.
41. Ward, J.M., Anver, M.R., Mahler J.F., and Devor-Henneman, D.E. (2000). Pathology of mice commonly used in genetic engineering (C57BL/6; 129; B6,129; and FVB/N). In: J.M. Ward, J.F. Mahler, R.R. Maronpot, J.P. Sundberg, and R.M. Frederickson, eds., Pathology of Genetically Engineered Mice (Iowa State University Press, Ames, IA), pp. 161-179.
42. Wolfe, J., and Sands, M.S. (1996). Murine mucopolysaccharidosis type VII: A model system for somatic gene therapy of the central nervous system. In: P. Lowenstein and L. Enquist, eds., Gene Transfer into Neurons: Towards Gene Therapy of Neurological Disorders (John Wiley & Sons, Essex, UK) pp. 263-274.
43. Woods, N.B., Bottero, V., Schmidt, M., von Kalle, C., and Verma, I.M. (2006). Gene therapy: Therapeutic gene causing lymphoma. Nature 440, 1123.
44. Xu, L., Haskins, M.E., Gao, C., Weil, M.A., O'Malley, T.M., Melniczek, J.R., O'Donnell, P.A., Mazrier, H., Ellinwood, N.M., and Ponder, K.P. (2002a). Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus-based retroviral vector results in long-term expression of β-glucuronidase in mucopolysaccharidosis VII dogs. Mol. Ther. 5, 141-153.
45. Xu, L., Mango, R.L., Sands, M.S., Haskins, M.E., Ellinwood, N.M., and Ponder, K.P. (2002b). Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy. Mol. Ther. 6, 745-758.
46. Xu, L., O'Malley, T., Sands, M.S., Wang, B., Meyerrose, T., Haskins, M.E., and Ponder, K.P. (2004). In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice. Mol. Ther. 10, 37-44.
47. Zychlinski, D., Schambach, A., Modlich, U., Maetzig, T., Meyer, J., Grassman, E., Mishra, A., and Baum, C. (2008). Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol. Ther. 16, 718-725.